Business & Industry
Business & Industry
Demand Sensing Analytics Improving Pharmaceutical Supply Chain Responsiveness
The pharmaceutical industry has traditionally relied on historical data and long-term forecasts to drive production and distribution decisions. However, this reactive approach often leads to significant inefficiencies, such as excessive inventory levels or critical stockouts. The introduction of demand...
Business & Industry
Supply Chain Resilience Planning Improving Pharmaceutical Operational Continuity
Global pharmaceutical markets require a sophisticated approach to risk management that moves beyond simple contingency planning. Establishing a framework for resilience involves identifying potential failure points across the entire lifecycle of a drug product, from raw material procurement to...
BioPharma
BioNTech and Gilead Partner for Pumitamig Clinical Trial
BioNTech SE has officially entered into a clinical trial collaboration and supply agreement with Gilead Sciences Inc. to evaluate the bispecific immunomodulator pumitamig in combination with the TROP2-directed antibody-drug conjugate (ADC) sacituzumab govitecan. Announced on October 22, 2026, this...
Business & Industry
Cencora to Acquire American Oncology Network in $2.4 Billion Deal
Cencora has signed a definitive agreement to acquire American Oncology Network, a physician-led network of more than 350 oncology providers operating across 21 states, in a transaction that values AON at approximately $2.4 billion. The deal is set to...
Business & Industry
Merck Acquires Silence Therapeutics for $1.3 Billion
Merck KGaA has entered into an agreement to acquire British biotech Silence Therapeutics for $1.3 billion in a fully cash-based transaction, securing the German pharmaceutical company's access to a compelling short interfering RNA (siRNA) drug development platform and a...
Business & Industry
METiS TechBio and Eli Lilly Join Forces for Next-Generation Tissue-Specific LNP Delivery Technologies
METiS TechBio has announced a strategic collaboration with Eli Lilly and Company to research and develop next-generation lipid nanoparticle (LNP)-based delivery solutions, leveraging METiS's proprietary AI-driven platform to enable precise, tissue-specific delivery of therapeutic modalities.
Under the terms of the...
Business & Industry
Eli Lilly and Mubadala Bio Sign Abu Dhabi GLP-1 Packaging Agreement
Eli Lilly and Mubadala Bio have signed a formal agreement to develop local pharmaceutical packaging and logistics capabilities for Lilly's GLP-1 medicines in Abu Dhabi, with the collaboration anchored by a dedicated 125,000 sqm site at Khalifa Economic Zones...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














